JPH08225568A5 - - Google Patents

Info

Publication number
JPH08225568A5
JPH08225568A5 JP1995312316A JP31231695A JPH08225568A5 JP H08225568 A5 JPH08225568 A5 JP H08225568A5 JP 1995312316 A JP1995312316 A JP 1995312316A JP 31231695 A JP31231695 A JP 31231695A JP H08225568 A5 JPH08225568 A5 JP H08225568A5
Authority
JP
Japan
Prior art keywords
phenyl
single bond
halo
hydroxy
benzyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1995312316A
Other languages
English (en)
Japanese (ja)
Other versions
JPH08225568A (ja
Filing date
Publication date
Priority claimed from US08/347,738 external-priority patent/US5521197A/en
Application filed filed Critical
Publication of JPH08225568A publication Critical patent/JPH08225568A/ja
Publication of JPH08225568A5 publication Critical patent/JPH08225568A5/ja
Pending legal-status Critical Current

Links

JP7312316A 1994-12-01 1995-11-30 ３−〈１，２，３，６−テトラヒドロ−〈１−アルキレンアリール〉−４−ピリジニル〉−および３−〈１−アルキレンアリール〉−４−ピペリジニル−１ｈ−インドール類：新規５−ｈｔ１ｆ作動薬 Pending JPH08225568A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US347738 1994-12-01
US08/347,738 US5521197A (en) 1994-12-01 1994-12-01 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Publications (2)

Publication Number Publication Date
JPH08225568A JPH08225568A (ja) 1996-09-03
JPH08225568A5 true JPH08225568A5 (enExample) 2005-09-02

Family

ID=23365048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7312316A Pending JPH08225568A (ja) 1994-12-01 1995-11-30 ３−〈１，２，３，６−テトラヒドロ−〈１−アルキレンアリール〉−４−ピリジニル〉−および３−〈１−アルキレンアリール〉−４−ピペリジニル−１ｈ−インドール類：新規５−ｈｔ１ｆ作動薬

Country Status (4)

Country Link
US (1) US5521197A (enExample)
EP (1) EP0714894A1 (enExample)
JP (1) JPH08225568A (enExample)
CA (1) CA2161209A1 (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9706969A (es) * 1995-03-20 1997-11-29 Lilly Co Eli 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos.
EP0749962B1 (en) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
EP1077213A3 (en) * 1996-06-14 2001-06-13 Eli Lilly And Company Inhibition of serotonin reuptake
US5962473A (en) * 1996-08-16 1999-10-05 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
AU4074897A (en) * 1996-09-18 1998-04-14 Eli Lilly And Company A method for the prevention of migraine
JP2001501946A (ja) * 1996-10-08 2001-02-13 イーライ・リリー・アンド・カンパニー 新規セロトニン５―ｈｔ▲下１ｆ▼アゴニスト
ZA979961B (en) * 1996-11-15 1999-05-05 Lilly Co Eli 5-HT1F agonists
EP0875513A1 (en) * 1997-04-14 1998-11-04 Eli Lilly And Company Substituted heteroaromatic 5-HT 1F agonists
US6380201B1 (en) 1997-08-05 2002-04-30 Eli Lilly And Company Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists
AR013669A1 (es) 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5905084A (en) * 1997-11-14 1999-05-18 Eli Lilly And Company 5-HTIF -agonists effective in treating migraine
ZA989389B (en) * 1997-11-14 2000-04-14 Lilly Co Eli Pyrrolo [3,2-b] pyridine processes and intermediates.
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
AU2031799A (en) 1998-01-14 1999-08-02 Uab Research Foundation, The Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
CA2327513A1 (en) * 1998-04-08 1999-10-14 James Albert Nelson N-aryloxyethyl-indoly-alkylamines for the treatment of depression
AU3476599A (en) * 1998-04-08 1999-10-25 American Home Products Corporation Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
AU4961499A (en) * 1998-06-26 2000-01-17 Eli Lilly And Company 5-HT1f agonists
HUP0102886A3 (en) * 1998-07-27 2002-12-28 Lilly Co Eli Treatment of anxiety disorders
US6242450B1 (en) * 1998-07-27 2001-06-05 Eli Lilly And Company 5-HT1F antagonists
AU1937300A (en) 1998-12-11 2000-06-26 Eli Lilly And Company Indole derivatives and their use as 5-HT1F agonists
US6337336B1 (en) 1999-04-22 2002-01-08 American Home Products Corporation Azaindole derivatives for the treatment of depression
AR028475A1 (es) * 1999-04-22 2003-05-14 Wyeth Corp Derivados de azaindol y uso de los mismos para la manufactura de un medicamento para el tratamiento de la depresion.
SE9903544D0 (sv) * 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
US6476051B2 (en) 1999-12-17 2002-11-05 Bristol-Myers Squibb Company Antipsychotic heterocycle compounds
GB2359078A (en) * 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) * 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
SE0003828D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
WO2002048105A2 (en) * 2000-11-16 2002-06-20 Wyeth Aryloxy piperidinyl derivatives for the treatment of depression
EP1349848A2 (en) 2000-11-17 2003-10-08 Wyeth Aryloxy piperidinyl indoles for treating depression
US6479537B2 (en) 2000-11-22 2002-11-12 American Cyanamid Company Synergistic ectoparasiticidal methods and compositions
AU2002236730B2 (en) * 2001-01-30 2006-06-15 Eli Lilly And Company Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-HT6 receptor
SE0101322D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
AR033287A1 (es) * 2001-05-09 2003-12-10 Lundbeck & Co As H Tratamiento del adhd
SE0102716D0 (sv) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221828D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
CN1777584A (zh) * 2003-04-18 2006-05-24 伊莱利利公司 作为5－ht1f激动剂的(哌啶氧基)苯基、(哌啶氧基)吡啶基、(哌啶硫基)苯基和(哌啶硫基)吡啶基化合物
UA82711C2 (en) * 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
AU2004291297B2 (en) * 2003-11-17 2011-06-23 Boehringer Ingelheim International Gmbh Novel piperidine-substituted indoles- or heteroderivatives thereof
GB0328243D0 (en) * 2003-12-05 2004-01-07 Astrazeneca Ab Methods
US20050245540A1 (en) * 2003-12-09 2005-11-03 Fujisawa Pharmaceutical Co., Ltd. New methods
US7312236B2 (en) 2003-12-17 2007-12-25 Eli Lilly And Company Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT1F agonists
JPWO2006082872A1 (ja) * 2005-02-04 2008-06-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 １−（ピペリジン−４−イル）−１ｈ−インドール誘導体
JP5080450B2 (ja) 2005-04-30 2012-11-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規なピペリジン置換インドール
JP4932717B2 (ja) 2005-05-11 2012-05-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピペリジン環を有するインドール誘導体の製造方法
WO2008049874A1 (en) 2006-10-27 2008-05-02 Boehringer Ingelheim International Gmbh Piperidyl-propane-thiol ccr3 modulators
HUE037261T2 (hu) 2009-04-02 2018-08-28 Colucid Pharmaceuticals Inc 2,4,6-trifluor-N-[6-(1-metil-piperidin-4-karbonil)-piridin-2-il]-benzamid, migrén kezelésére orális vagy intravénás úton
CA2795062A1 (en) 2010-04-02 2011-10-06 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
CN106045967B (zh) * 2015-04-08 2020-04-21 广东东阳光药业有限公司 取代杂环化合物及其在药物上的应用
CN106045966B (zh) * 2015-04-08 2020-04-21 广东东阳光药业有限公司 取代杂环化合物及其在药物上的应用
TWI826514B (zh) 2018-09-04 2023-12-21 美商美國禮來大藥廠 用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
AR119319A1 (es) 2019-07-09 2021-12-09 Lilly Co Eli Procesos e intermediario para la preparación a gran escala de hemisuccinato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida y preparación de acetato de 2,4,6-trifluoro-n-[6-(1-metil-piperidina-4-carbonil)-piridin-2-il]-benzamida

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193584B1 (enExample) * 1972-07-28 1975-08-08 Roussel Uclaf
US3947578A (en) * 1972-07-28 1976-03-30 Roussel Uclaf Omega-[4-(3"-indolyl)-piperidino]-alkyl-arylketones as nevroleptics
FR2421899A1 (fr) * 1978-01-16 1979-11-02 Roussel Uclaf Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
GB8419575D0 (en) 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
DE19775091I2 (de) * 1990-06-07 2007-05-24 Astrazeneca Ab Therapeutische heterocyclische Verbindungen
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5118691A (en) * 1990-09-20 1992-06-02 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5187280A (en) * 1990-09-20 1993-02-16 Warner-Lambert Company Substituted tetrahydropyridines and their use as central nervous system agents
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (enExample) * 1991-02-12 1995-11-21 Pfizer
KR0184911B1 (ko) * 1991-11-25 1999-05-01 알렌 제이. 스피겔 인돌유도체
US5360735A (en) 1992-01-08 1994-11-01 Synaptic Pharmaceutical Corporation DNA encoding a human 5-HT1F receptor, vectors, and host cells
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them

Similar Documents

Publication Publication Date Title
JPH08225568A5 (enExample)
EP0809499B1 (en) Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
EP0935465B1 (en) Novel substituted imidazole compounds
US5849739A (en) 5-arylindole derivatives
US5434154A (en) Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkylpiperazines
AU709370B2 (en) Novel compounds
US6441000B1 (en) Compounds useful in therapy
US5077293A (en) 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) Antimigraine alkoxypyrimidine derivatives
JPH066565B2 (ja) 光学活性なベンゼンスルホンアミド誘導体の製造法
JP2005516969A (ja) メタボトロピックグルタミン酸受容体−５のヘテロアリール置換ピロールモジュレーター
EP0831830A1 (en) Imidazole compounds
IL99908A (en) 3-amido and 3-sulfamido-indolyl derivatives a process for their preparation and pharmaceutical compositions containing them
NO166126B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
JPS6322056A (ja) オレフイン性化合物の製造法
NZ545694A (en) Azole-based kinase inhibitors
JP2005504800A (ja) ピリミジノン化合物及びその薬剤として許容される塩の製造方法
SK282234B6 (sk) Spôsob výroby n-metyl-3-(1-metyl-4-piperidinyl)-1h-indol-5-etánsulfónamidu a medziprodukt
JP2004516290A (ja) 新規プロセス
WO1988001270A1 (en) Pyridopyrimidinediones
JPS63145286A (ja) 二環性イミダゾ−ル誘導体
KR20120084286A (ko) 나라트립탄의 합성방법
JPH0678335B2 (ja) アザスピロキノロン化合物、その製法および抗菌組成物
JPH10501229A (ja) １−ブチル−２−［２’−（２ｈ−テトラゾル−５−イル）−ビフェニル−４−イルメチル］−１ｈ−インドール−３−カルボン酸の製法
KR860007219A (ko) 설포닐아미노에틸 화합물의 제조방법